Partner Daniel (Dan) Kaplan was quoted in an article in The American City Business Journals titled “Omicron sharpens labor pains for short-staffed businesses” that discusses how the Omicron variant is currently challenging employers by way of staffing shortages.
Kaplan shared that his clients are seeing considerably more absences, which is leading to more mask requirements and additional encouragement to be vaccinated. He added, “Employers need employees. If employees quit because they are mandated to get a vaccination — that is not good for employers. Similarly, if employees are ill because they are unvaccinated and therefore out of the workforce, even temporarily, that too is bad for employers.”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”